This report presents a plan of action for introducing a "program to reduce the incidence of pediatric adverse drug events (pADEs) and harm ... [that] combine[s] leadership strategies, software (healthcare IT), hardware (drug compounding systems, drug delivery technology, and physiological monitoring systems), and most importantly people (changes in clinical practice, protocols and education)" to protect pediatric patients.
Yang S, Lam JT, Sims N, et al. Actionable Patient Safety Solution (APSS) #3D: Pediatric Adverse Drug Events. Patient Safety Movement Foundation. February 2017 (http://patientsafetymovement.org/wp-content/uploads/2016/06/APSS-3D_-Pediatric-Adverse-Drug-Events.pdf).
Patient Safety Movement Foundation
Health and Medical Administration Commons, Other Pharmacy and Pharmaceutical Sciences Commons, Pediatrics Commons, Pharmaceutical Preparations Commons, Pharmacy Administration, Policy and Regulation Commons